149 related articles for article (PubMed ID: 32216739)
1. Prediabetic Dysglycemia: Call for Action.
Sjöholm Å
Curr Diabetes Rev; 2021; 17(1):21-25. PubMed ID: 32216739
[TBL] [Abstract][Full Text] [Related]
2. [Possible to prevent prediabetes from progressing to manifest type 2 diabetes].
Sjöholm Å
Lakartidningen; 2019 Apr; 116():. PubMed ID: 31192428
[TBL] [Abstract][Full Text] [Related]
3. Is metabolic syndrome a condition independent of prediabetes and type 2 diabetes mellitus? A report from Turkey.
Uzunlulu M; Oguz A
Endocr J; 2007 Dec; 54(5):745-50. PubMed ID: 17878610
[TBL] [Abstract][Full Text] [Related]
4. Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose.
DeFronzo RA; Abdul-Ghani M
Am J Cardiol; 2011 Aug; 108(3 Suppl):3B-24B. PubMed ID: 21802577
[TBL] [Abstract][Full Text] [Related]
5. Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients.
Madhu SV; Muduli SK; Avasthi R
Diabetes Technol Ther; 2013 Jun; 15(6):461-5. PubMed ID: 23631606
[TBL] [Abstract][Full Text] [Related]
6. Incidence and Predictors of Dysglycemia and Regression to Normoglycemia in Indian Adolescents and Young Adults: 10-Year Follow-Up of the ORANGE Study.
Mehreen TS; Kamalesh R; Pandiyan D; Kumar DS; Anjana RM; Mohan V; Ranjani H
Diabetes Technol Ther; 2020 Dec; 22(12):875-882. PubMed ID: 32349530
[No Abstract] [Full Text] [Related]
7. Pre-diabetes, dysglycaemia and early glucose intolerance and vascular health.
Joshi SR; Karne R
J Assoc Physicians India; 2007 Dec; 55():829-31. PubMed ID: 18405127
[No Abstract] [Full Text] [Related]
8. Identification of impaired fasting glucose, healthcare utilization and progression to diabetes in the UK using the Clinical Practice Research Datalink (CPRD).
Hong JL; McNeill AM; He J; Chen Y; Brodovicz KG
Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1375-1386. PubMed ID: 27193175
[TBL] [Abstract][Full Text] [Related]
9. Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease-A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V.
Ferrannini G; De Bacquer D; De Backer G; Kotseva K; Mellbin L; Wood D; Rydén L;
Diabetes Care; 2020 Apr; 43(4):726-733. PubMed ID: 32079627
[TBL] [Abstract][Full Text] [Related]
10. Prior lactation reduces future diabetic risk through sustained postweaning effects on insulin sensitivity.
Bajaj H; Ye C; Hanley AJ; Connelly PW; Sermer M; Zinman B; Retnakaran R
Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E215-E223. PubMed ID: 27965206
[TBL] [Abstract][Full Text] [Related]
11. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
Flórez H
Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
[TBL] [Abstract][Full Text] [Related]
12. Dysglycemia/prediabetes and cardiovascular risk factors.
Hanna-Moussa A; Gardner MJ; Kurukulasuriya LR; Sowers JR
Rev Cardiovasc Med; 2009; 10(4):202-8. PubMed ID: 20065930
[TBL] [Abstract][Full Text] [Related]
13. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
Snehalatha C; Ramachandran A; Satyavani K; Latha E; Viswanathan V
Diabetes Care; 1998 Jan; 21(1):76-9. PubMed ID: 9538973
[TBL] [Abstract][Full Text] [Related]
14. Dysglycemia in Pregnancy and Maternal/Fetal Outcomes.
Silva CM; Arnegard ME; Maric-Bilkan C
J Womens Health (Larchmt); 2021 Feb; 30(2):187-193. PubMed ID: 33147099
[TBL] [Abstract][Full Text] [Related]
15. Identification and treatment of prediabetes to prevent progression to type 2 diabetes.
Fonseca VA
Clin Cornerstone; 2007; 8(2):10-8; discussion 19-20. PubMed ID: 18357952
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the utility of self-reported questionnaire data to screen for dysglycemia in young adults: Findings from the US National Health and Nutrition Examination Survey.
Srugo SA; de Groh M; Jiang Y; Morrison HI; Villeneuve PJ
Prev Med; 2019 Mar; 120():50-59. PubMed ID: 30639079
[TBL] [Abstract][Full Text] [Related]
17. Impaired glucose tolerance and impaired fasting glucose.
Rao SS; Disraeli P; McGregor T
Am Fam Physician; 2004 Apr; 69(8):1961-8. PubMed ID: 15117017
[TBL] [Abstract][Full Text] [Related]
18. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
[TBL] [Abstract][Full Text] [Related]
19. Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1.
Sosenko JM; Palmer JP; Rafkin-Mervis L; Krischer JP; Cuthbertson D; Mahon J; Greenbaum CJ; Cowie CC; Skyler JS;
Diabetes Care; 2009 Sep; 32(9):1603-7. PubMed ID: 19487644
[TBL] [Abstract][Full Text] [Related]
20. Benefit of lifestyle-based T2DM prevention is influenced by prediabetes phenotype.
Campbell MD; Sathish T; Zimmet PZ; Thankappan KR; Oldenburg B; Owens DR; Shaw JE; Tapp RJ
Nat Rev Endocrinol; 2020 Jul; 16(7):395-400. PubMed ID: 32060416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
